3D BioFibR produces naturally sourced, high value biofibers, such as collagen and spider silk, for potential use in biomedical engineering, green textiles, defense, and aerospace applications. The Company’s proprietary dry-spinning process is faster than current manufacturing processes and preserves the natural properties of the biofibre proteins. 3D BioFibR is refining its large-scale production of CollaFibR™, a strong, high-quality collagen fibre, to be weaved into commercial products for the 3D tissue culture and tissue engineering market. For more information, visit www.3DBioFibR.com. This news release contains “forward-looking statements,” which reflect the current expectations of the Company’s management for future growth, results of operations, performance and business prospects. Forward-looking statements involve significant known and unknown risks, uncertainties and assumptions.